Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LeMaitre VascularLMAT +0.78%100 PEG Ratio is 2.15 as of Aug. 07, 2026, which is 19% below its 10-year median of 2.66. GuruFocus rates LMAT with a GF Score™ of 100/100 and a GF Value™ of $95.26 (Modestly Undervalued). Among 207 Medical Devices & Instruments companies, LeMaitre Vascular ranks worse than 50.24% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for LeMaitre Vascular's PEG Ratio or its related term are showing as below:
LMAT'
s PEG Ratio Range Over the Past 10 Years
Min: 0.94 Med: 2.66 Max: 9.52
Current: 2.03
During the past 13 years, LeMaitre Vascular's highest PEG Ratio was 9.52. The lowest was 0.94. And the median was 2.66.
LMAT's PEG Ratio is ranked worse than 50.24% of 207
companies
in the Medical Devices & Instruments industry
Industry Median: 2.01
vs LMAT: 2.03
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
LeMaitre Vascular (NAS:LMAT) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
LeMaitre Vascular PEG Ratio Related Terms
LeMaitre Vascular PEG Ratio Historical Data
* Premium members only.
The historical data trend for LeMaitre Vascular's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LeMaitre Vascular PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's PEG Ratio distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
LeMaitre Vascular (LMAT) has a PEG Ratio of 2.15 as of Aug. 07, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on LeMaitre Vascular and its competitors. This is 19% below median its historical median of 2.66. Over the past decade, LeMaitre Vascular's PEG Ratio has ranged from 0.94 to 9.52. According to the industry distribution chart, LeMaitre Vascular ranks #104 out of 207 companies in the Medical Devices & Instruments industry, placing it in the top 50.2%.
Is LeMaitre Vascular's PEG Ratio too high?
LeMaitre Vascular's current PEG Ratio of 2.15 is 19% below median its 10-year median of 2.66. Over the past 10 years, this metric has ranged from a low of 0.94 to a high of 9.52. The Medical Devices & Instruments industry median PEG Ratio is 2.01. LeMaitre Vascular's value of 2.15 is 7% above this industry median. Based on the distribution chart, LeMaitre Vascular ranks #104 out of 207 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, LeMaitre Vascular has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LeMaitre Vascular's PEG Ratio compare to PLSE and XRAY?
According to the Medical Devices & Instruments industry distribution chart, LeMaitre Vascular ranks #104 out of 207 companies for PEG Ratio. This places LeMaitre Vascular in the lower half of its industry. The industry median PEG Ratio is 2.01. LeMaitre Vascular's value of 2.15 is 7% above this benchmark. Historically, LeMaitre Vascular's own PEG Ratio has ranged from 0.94 to 9.52 over the past decade. While the company's 10-year median is 2.66 vs. the industry median of 2.01, LeMaitre Vascular has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 2.01, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LeMaitre Vascular's current PEG Ratio of 2.15 is 7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on LeMaitre Vascular and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LeMaitre Vascular's current PEG Ratio is 2.15, which is 19% below median its own 10-year median of 2.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeMaitre Vascular stock overvalued right now?
Based on GuruFocus' analysis, LeMaitre Vascular (LMAT) is currently considered Modestly Undervalued. The stock's GF Value™ is $95.26, compared to a current price of $81.45 — trading 14.5% below its estimated fair value. The current PEG Ratio is 2.15, which is 19% below median its 10-year median of 2.66 and 7% above the Medical Devices & Instruments industry median of 2.01. LeMaitre Vascular's overall GF Score™ is 100/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For LeMaitre Vascular (LMAT), the current PEG Ratio is 2.15 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LeMaitre Vascular (LMAT) Overvalued in 2026?
Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued.
The current stock price of $81.45 is trading 14.5% below its estimated GF Value™ of $95.26.
GuruFocus considers LeMaitre Vascular to be Modestly Undervalued.
Key valuation signals for LMAT:
PEG Ratio: 2.15 (19% below median its 10-year median of 2.66)
GF Value™: $95.26 vs. price of $81.45 (14.5% below fair value)
Industry Position: 7% above the Medical Devices & Instruments median (#104 of 207)
No single metric tells the full story. See the LMAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
100GF Score
Get the complete analysis for LMAT
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMAT has been successfully added to your 
